Eli Lilly & Co. (NYSE:LLY)

Eli Lilly Logo

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share ...
Read Full Story »
Prescription drugs

Top Credit Suisse Major Pharma Stock Picks to Buy

Considering the health care sector has been on fire for the first quarter of 2015, analysts are putting more value in biotechs and big pharmaceuticals. Credit Suisse is no different. ...
Read Full Story »
investing

3 Surprising Overlooked Stocks That Could Have Big Upside

If there is one thing Wall Street has been guilty of over the years, it is a sort of herd mentality. This that leads to “overcrowded” trades, where everybody is ...
Read Full Story »
Pills

3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings

One thing investors look for in an aging bull market, especially one trading near all-time highs, is rising earnings. That is the only way to justify multiples that creep up ...
Read Full Story »
Prescription drugs

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

While most people consider big pharmaceutical stocks very defensive, the fact of the matter is that they offer investors terrific growth and income possibilities, which can lead to outstanding total ...
Read Full Story »
generic drugs

4 Pharmaceutical Stocks to Buy for Outperformance in 2015

It is a nice change sometimes when the prognosticators on Wall Street, who tend to follow each other's lead, are not only right, but investors come out on top. Almost ...
Read Full Story »
Pills

4 Top Pharmaceutical Stocks to Buy for Market Safety

Tuesday's big downward move reminded everybody that while things look encouraging for the stock market long term, momentum stocks tend to get absolutely eviscerated when a big volatility jump helps ...
Read Full Story »
Pfizer logo

Jefferies 4 Top Pharmaceutical Stocks to Buy

With the stock market hitting all-time highs, many investors are starting to wonder which sectors still hold value. Although seeming rich, the market continues climbing a wall of worry to ...
Read Full Story »
Pills

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today. ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Stocks were mixed on Thursday after two days of losses. While sell-offs have been sharp and out of the blue, investors have time and again shown that they will buy stocks on ...
Read Full Story »
Pills

5 Top Pharmaceutical Stock Picks for 2015

After an outstanding 2014, the health care sector could be primed for yet another solid performance in 2015. While many analysts on Wall Street are very positive on the group, ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Stocks were trying to post a recovery on Thursday morning on the heels of three days worth of energy-related selling. Despite a relatively harsh drop, investors have proven over and ...
Read Full Story »
135093244

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

Stocks have enjoyed yet another wonderful year in 2014, and the bull market is now more than five and a half years old. With the S&P 500 index up almost ...
Read Full Story »
biotech

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

One sad thing for almost every citizen in the United States is that at one point almost all of us will either have cancer or have a friend or relative ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Eli Lilly, Enphase, Lululemon, SodaStream, Yelp and More

Stocks were lower on Thursday after weak overseas trading. Investors are braced for Friday's key unemployment and payrolls report, and they are still looking for upside from their investment funds. ...
Read Full Story »